Entrada Therapeutics Inc had a revenue of 37.40M in the quarter ending Dec 31, 2024, with 91.10%. This bring the company's revenue in the last twelve months to 210.78M, Increased -2.07%. In the fiscal year ending Dec 31, 2024, Entrada Therapeutics Inc had annual revenue of 210.78M with 63.38% growth.